Company facts
- Headquarters
- Los Angeles, California
- Most recent report
- 10-Q, filed Aug 12, 2026
- Incorporated
- Washington
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 921114
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 84
News 8 of 287
- 8-K Quarterly results Aug 12, 2026
- 8-K Current report on a material event Jul 20, 2026
- 8-K Leadership change Jul 20, 2026
- 8-K Current report on a material event Jul 13, 2026
- 8-K/A Leadership change Jun 24, 2026
- 8-K Other events Jun 23, 2026
- 8-K Shareholder vote results Jun 16, 2026
- 8-K Quarterly results May 13, 2026
Prospectuses and Registrations 8 of 104
- S-8 Registration statement for an employee plan Jul 13, 2026
- 424B5 Prospectus supplement for an offering Dec 1, 2025
- S-8 Registration statement for an employee plan Aug 13, 2025
- S-3 Shelf registration statement Aug 13, 2025
- S-8 Registration statement for an employee plan Jan 23, 2024
- S-8 Registration statement for an employee plan Nov 15, 2023
- 424B3 Prospectus supplement for an offering Apr 6, 2023
- S-3/A Shelf registration statement, amended Mar 28, 2023
Proxies 8 of 52
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Aug 3, 2023
- DEF 14A Proxy statement for a shareholder vote Aug 3, 2023
- PRE 14A Preliminary proxy statement Jul 24, 2023
- DEF 14A Proxy statement for a shareholder vote Oct 17, 2022
- DEF 14A Proxy statement for a shareholder vote Mar 9, 2022
Ownership 8 of 333
- 4 Insider reported a trade Jul 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended May 13, 2026
- 4 Insider reported a trade Apr 28, 2026
- 3 Insider reported their initial holding Apr 28, 2026
- 4 Insider reported a trade Mar 17, 2026
- 4 Insider reported a trade Mar 17, 2026
- 4 Insider reported a trade Mar 11, 2026
- 4 Insider reported a trade Mar 11, 2026
Other 8 of 140
- ARS Annual report sent to shareholders Apr 27, 2026
- EFFECT Notice that a registration became effective Aug 22, 2025
- CORRESP Reply to SEC staff Aug 20, 2025
- UPLOAD Comment letter from SEC staff Aug 15, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- UPLOAD Comment letter from SEC staff Nov 13, 2023
- CORRESP Reply to SEC staff Nov 7, 2023
Everything here comes from Armata Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.